Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-08

Clinical Trial Update: Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.

View source ↗

Summary

This clinical trial update describes a long-term observational study assessing the safety and efficacy of FURESTEM-AD Inj. in people with atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FURESTEM-AD Inj.

Snippet

Sponsor: Kang Stem Biotech Co., Ltd. | Conditions: Atopic Dermatitis | Status: UNKNOWN